X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Researchers Push For Antibiotic Nod In Brazil, India, And SA

    Serum Institute Wins USFDA Nod To Export Novavax COVID Jab

    Serum Institute Wins USFDA Nod To Export Novavax COVID Jab

    Pfizer, Moderna & AstraZeneca - Their COVID-19 vaccine comparison

    The Fourth COVID-19 Vaccine Reduces Senior Mortality By 72%

    NIH Initiates Clinical Study of mRNA Nipah Virus Vaccine

    NIH Initiates Clinical Study of mRNA Nipah Virus Vaccine

    As Medical Uses Cope Up, Genomic Studies Reap Scale Benefits

    As Medical Uses Cope Up, Genomic Studies Reap Scale Benefits

    Novavax to Participate in University of Oxford Com-COV2 Study Comparing Mixed COVID-19 Vaccine Combinations

    FDA Clears Novavax COVID-19 Vaccine As Fourth Option In US

    Australia Creates A Novel Stem Cell Production Technique

    Australia Creates A Novel Stem Cell Production Technique

    U.S. Officials Clear COVID-19 Jab For Infants, Preschoolers

    U.S. Officials Clear COVID-19 Jab For Infants, Preschoolers

    Bispecific Blood Cancer Drug By Roche Globally Approved

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Researchers Push For Antibiotic Nod In Brazil, India, And SA

    Serum Institute Wins USFDA Nod To Export Novavax COVID Jab

    Serum Institute Wins USFDA Nod To Export Novavax COVID Jab

    Pfizer, Moderna & AstraZeneca - Their COVID-19 vaccine comparison

    The Fourth COVID-19 Vaccine Reduces Senior Mortality By 72%

    NIH Initiates Clinical Study of mRNA Nipah Virus Vaccine

    NIH Initiates Clinical Study of mRNA Nipah Virus Vaccine

    As Medical Uses Cope Up, Genomic Studies Reap Scale Benefits

    As Medical Uses Cope Up, Genomic Studies Reap Scale Benefits

    Novavax to Participate in University of Oxford Com-COV2 Study Comparing Mixed COVID-19 Vaccine Combinations

    FDA Clears Novavax COVID-19 Vaccine As Fourth Option In US

    Australia Creates A Novel Stem Cell Production Technique

    Australia Creates A Novel Stem Cell Production Technique

    U.S. Officials Clear COVID-19 Jab For Infants, Preschoolers

    U.S. Officials Clear COVID-19 Jab For Infants, Preschoolers

    Bispecific Blood Cancer Drug By Roche Globally Approved

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Drug Development FDA Approvals

Researchers Push For Antibiotic Nod In Brazil, India, And SA

Content Team by Content Team
19th July 2022
in FDA Approvals, News

According to a paper examining the present environment for antimicrobial development in Brazil, India, and South Africa, lowering regulatory barriers to hasten the clearance of novel antibiotics will aid in the development and accessibility of those drugs.

Given that antibiotics are a cornerstone of contemporary medicine, antimicrobial resistance (AMR) is a major problem for the healthcare industry, especially in countries like Brazil, India, and South Africa. The emergence, transmission, and effects of AMR can be slowed down by using currently available antibiotics appropriately and developing novel treatments that target drug-resistant diseases.

However, despite the demand for novel antibiotics, R & D has fallen short. This is mostly because antibiotics are expensive to produce and have a limited market due to their high cost and limited application. According to the paper, overcoming regulatory barriers to expedite the clearance of novel antibiotics can assist in enhancing their development and access, even though monetary incentives and market changes are essential for lasting progress.

Antibiotics are distinct from many other prescription medications in many ways, including the need for the regular implementation of new drugs to substitute ones to which opposition has evolved and the depth of trials to identify drugs that are efficacious against drug-resistant pathogens, said Dr. Ramanan Laxminarayan, director of One Health Trust.

One Health Trust discussed the present environment for antimicrobial innovation in a paper backed by the AMR Industry Alliance, concentrating on regulatory issues and chances for the clearance of novel antibiotics in Brazil, India, and South Africa. The results of the landscape analysis show how crucial it is to formally recognise new antimicrobials that target serious or life-threatening infections as an urgent unmet medical need and include them in regulatory frameworks for expedited drug approval.

The following suggestions are made to hasten the approval of antibiotics:

  • Accelerated approval paths were made possible by designating a specific category within the legal regime for antibiotics that fight serious and life-threatening diseases.
  • Utilizing current initiatives for TB, HIV, and COVID-19 medication expedited approval of antibiotics for critical and life-threatening diseases, such as multidrug-resistant infections.
  • Enhancing the ability of regulatory bodies to handle the complexity of AMR and innovative clinical trials.
  • Encouraging regulatory harmonisation to make dependency pathways adoption easier for rapid approval of antibiotics.

The increased morbidity and mortality brought on by antibiotic resistance, particularly in low- and middle-income nations, has been well documented, according to Dr. Laxminarayan. Antibiotic usage is commonly and correctly blamed for the issue, but the underlying issue of the absence of antibiotic availability has received insufficient attention. This paper correctly recognises the opportunity to enhance the wider access to new antibiotics as the recognition of AMR in regulatory frameworks for medicinal approvals.

Previous Post

India Administers 2bn COVID-19 Jabs, Cases At 4 Month-High

Related Posts

India Administers 2bn COVID-19 Jabs, Cases At 4 Month-High
Health & Nutrition

India Administers 2bn COVID-19 Jabs, Cases At 4 Month-High

19th July 2022
Serum Institute Wins USFDA Nod To Export Novavax COVID Jab
FDA Approvals

Serum Institute Wins USFDA Nod To Export Novavax COVID Jab

19th July 2022
T2 Biosystems T2SARS-CoV-2 Panel Detects Omicron Subvariants
News

The US Has Prolonged The COVID-19 Public Health Emergency

18th July 2022
Pfizer, Moderna & AstraZeneca - Their COVID-19 vaccine comparison
News

The Fourth COVID-19 Vaccine Reduces Senior Mortality By 72%

18th July 2022
NIH Initiates Clinical Study of mRNA Nipah Virus Vaccine
Clinical Trials

NIH Initiates Clinical Study of mRNA Nipah Virus Vaccine

18th July 2022
Could The Long Deckline In Biotechnology M&A Be Ending
Featured

Could The Long Deckline In Biotechnology M&A Be Ending

16th July 2022

Latest News

FDA Approvals

Researchers Push For Antibiotic Nod In Brazil, India, And SA

19th July 2022
India Administers 2bn COVID-19 Jabs, Cases At 4 Month-High
Health & Nutrition

India Administers 2bn COVID-19 Jabs, Cases At 4 Month-High

19th July 2022
Serum Institute Wins USFDA Nod To Export Novavax COVID Jab
FDA Approvals

Serum Institute Wins USFDA Nod To Export Novavax COVID Jab

19th July 2022
T2 Biosystems T2SARS-CoV-2 Panel Detects Omicron Subvariants
News

The US Has Prolonged The COVID-19 Public Health Emergency

18th July 2022
Pfizer, Moderna & AstraZeneca - Their COVID-19 vaccine comparison
News

The Fourth COVID-19 Vaccine Reduces Senior Mortality By 72%

18th July 2022
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In